Bumper Offer - Urjas oil Just @ Rs. 1
Carvedil 25 Mg Tablet is a prescription drug, available for use as Tablet. It is typically used for the treatment of High BP. Secondary and off-label uses of Carvedil 25 Mg Tablet have also been mentioned below.
The correct dosage of Carvedil 25 Mg Tablet depends on the patient's age, gender, and medical history. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Refer to the dosage section for a detailed discussion.
While these are the most often observed Carvedil 25 Mg Tablet side effects, there are can be others also. These have been listed below. Normally, these side effects of Carvedil 25 Mg Tablet are not long lasting and go away when the treatment is finished. If, however, they worsen or do not go away, please speak with your physician.
In addition, Carvedil 25 Mg Tablet's effect is Moderate during pregnancy and Safe for lactating mothers. Further, the section on Carvedil 25 Mg Tablet related warnings talks about Carvedil 25 Mg Tablet's effects on the liver, heart and kidney.
Carvedil 25 Mg Tablet is not recommended if you suffer from certain medical conditions as it can have adverse effects. Diabetes, Bradycardia (Slow Heart Rate), Peripheral Vascular Disease (PVD) are examples of such conditions. The section on Carvedil 25 Mg Tablet contraindications lists all such conditions.
Additionally, Carvedil 25 Mg Tablet may also adversely react with other medicines. Refer to the list below for further details.
In addition to the above precautions for Carvedil 25 Mg Tablet, it is important to know that it is not safe while driving, and is not habit-forming.
Carvedil 25 Mg Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Based on research, the following side effects have been observed when Carvedil 25 Mg Tablet is used -
Severe
Moderate
Mild
Is the use of Carvedil 25 Mg Tablet safe for pregnant women?
Pregnant women may experience moderate side effects from Carvedil. It is best to stop taking Carvedil immediately and inform your doctor if you notice any discomfort.
Is the use of Carvedil 25 Mg Tablet safe during breastfeeding?
Carvedil is safe for breastfeeding women.
What is the effect of Carvedil 25 Mg Tablet on the Kidneys?
Using Carvedil does not have any harmful effects on kidneys.
What is the effect of Carvedil 25 Mg Tablet on the Liver?
Side effects of Carvedil rarely affect the liver.
What is the effect of Carvedil 25 Mg Tablet on the Heart?
Very few cases of side effects of Carvedil on the heart have been reported.
Carvedil 25 Mg Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Carvedil 25 Mg Tablet unless your doctor advises you to do so -
Is this Carvedil 25 Mg Tablet habit forming or addictive?
No, there is no any evidence that Carvedil 25 Mg Tablet is addictive.
Is it safe to drive or operate heavy machinery when consuming?
No, you should not drive or operate heavy machinery after taking Carvedil 25 Mg Tablet as you may feel sleepy.
Is it safe?
Carvedil 25 Mg Tablet should be used only after doctor's advice.
Is it able to treat mental disorders?
No, the use of Carvedil 25 Mg Tablet in mental disorders is not effective.
Interaction between Food and Carvedil 25 Mg Tablet
When consumed with certain foods, Carvedil 25 Mg Tablet may take longer to have an effect. Contact your doctor about this.
Interaction between Alcohol and Carvedil 25 Mg Tablet
Taking alcohol with Carvedil 25 Mg Tablet can be dangerous.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 287-288
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 564
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Coreg® (carvedilol)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Coreg Cr® (carvedilol phosphate)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Vedilol® (carvedilol)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 287-288
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 564
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Coreg® (carvedilol)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Coreg Cr® (carvedilol phosphate)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Vedilol® (carvedilol)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 287-288
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 564
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Coreg® (carvedilol)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Coreg Cr® (carvedilol phosphate)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Vedilol® (carvedilol)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 287-288
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 564
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Coreg® (carvedilol)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Coreg Cr® (carvedilol phosphate)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Vedilol® (carvedilol)
